On March 6, an open letter by Geert Vanden Bossche, PhD, DVM, and a video interview of him by Phillip McMillan, MD, from a company called Vejon Health, were posted online.
On the surface, Vanden Bossche appears to perhaps be addressing credible concerns about Covid.
He’s saying that the current crop of Covid vaccines will cause the novel coronavirus to mutate into a “super-infectious virus.” And therefore he’s calling for an immediate halt of the use of the current vaccines.
If humans are “committed to perpetuating our species, we have no choice but to eradicate these highly infectious viral variants” via “large vaccination campaigns,” Vanden Bossche claims at the conclusion of his open letter. But in contrast to the currently used Covid vaccines, these new vaccines must focus on stimulation of mass production of the component of the immune system known as natural killer cells, he asserts.
However, Vanden Bossche bases his views on unproven hypotheses. This is similar to, and builds on, high-profile modeling-paper authors who use theoretical frameworks to inflame fears about the supposed dangerousness of the new variants.
Despite this, Vanden Bossche’s views were very quickly and positively received by high-profile vaccine sceptics such as Dell Bigtree in his March 11 episode (starting at 57:25) and Vernon Coleman in his March 13 video and article.
Bigtree and Coleman virtually unquestioningly accept and amplify Vanden Bossche’s views. They strongly insinuate to their overwhelmingly credulous subscribers that there’s virtually no fact-checking or pause for sober second thought required.
But from my experience as a former long-time medical writer and journalist (1988-2016) — particularly a four-month stint with media-relations giant FleishmanHillard in 1994 (yes, I’ve worked for the dark side) — this has all the hallmarks of a drug-company astroturfcampaign.
It’s another step in the decades-long erasure of the fact that our sophisticated and highly effective immune systems work well and don’t need any assistance from the biomedical/pharmaceutical industry.
Read more: The Curious Case of Geert Vanden Bossche